In addition, the GITR-GITRL interaction has been known to attenuate Treg cell function via the loss of Foxp3 expression as well as enhance tumor-specific effector CD4+ and CD8+ T cell functions [27], [39], [48], [49]. The gene discussed is TNFSF18; the disease is neoplasm.